Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Cancer
|
November 1, 1996
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma
J Rubin, J G Gallagher, G Schroeder, et al.
The American Journal of Medicine
|
February 1, 1983
Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants
J W Kugler, J O Armitage, C M Helms, et al.
Transplantation
|
May 1, 1985
The use of partially matched, unrelated donors in clinical bone marrow transplantation
R D Gingrich, C W Howe, N E Goeken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1997
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer
J A Martenson, R Swaminathan, P A Burch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1994
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group
C L Loprinzi, J A Laurie, H S Wieand, et al.
Cancer
|
May 15, 1991
A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
J E Krook, M J O'Connell, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer
G F Fleming, J W Kugler, P C Hoffman, et al.
Investigational New Drugs
|
August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
P A Burch, A M Bernath, T L Cascino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer
C L Loprinzi, R M Goldberg, J Q Su, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2005
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
C X Ma, P Steen, K M Rowland, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Cancer
|
November 1, 1996
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma
J Rubin, J G Gallagher, G Schroeder, et al.
The American Journal of Medicine
|
February 1, 1983
Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants
J W Kugler, J O Armitage, C M Helms, et al.
Transplantation
|
May 1, 1985
The use of partially matched, unrelated donors in clinical bone marrow transplantation
R D Gingrich, C W Howe, N E Goeken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1997
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer
J A Martenson, R Swaminathan, P A Burch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1994
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group
C L Loprinzi, J A Laurie, H S Wieand, et al.
Cancer
|
May 15, 1991
A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
J E Krook, M J O'Connell, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer
G F Fleming, J W Kugler, P C Hoffman, et al.
Investigational New Drugs
|
August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
P A Burch, A M Bernath, T L Cascino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer
C L Loprinzi, R M Goldberg, J Q Su, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2005
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
C X Ma, P Steen, K M Rowland, et al.
Page
of 4